SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

BrainStorm Cell Therapeutics Inc. (BCLI) Reports Q3 2026 Results; No Figures Provided

BrainStorm Cell Therapeutics announced financial results for the quarter ended September 30, 2026, but the release provides no financial figures. It said preparations continue for the Phase 3b ENDURANCE study of NurOwn in ALS.Material DetailsContext by AI AnalystThe update places BrainStorm in clin…

BCLI

Related stories